AI imaging firm Body Vision Medical will preview its latest software for the LungVision imaging platform at the American Association for Bronchology and Interventional Pulmonology (AABIP) 2023 annual conference in Chicago.
The software update includes a redesign of the user interface, as well as new features, the company said. This includes an AI-driven suggested lesion location feature that helps localize pulmonary lesions on real-time, intraoperative images produced by the system during diagnostic bronchoscopy.
The new version of LungVision will be preloaded as the standard software on all new LungVision systems beginning September 2023, according to Body Vision.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
